Skip to main content

Table 2 Assays of Liver Injury or Hepatic Steatosis

From: Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment

Assay§

LFD+VEH

LFD+NDEA

HFD+VEH

HFD+NDEA

F-Ratio

P-Value

Serum ALT (U/L)

17.3 ± 0.9

23.8 ± 3.9

30.6 ± 1.8**

33.5 ± 2.1**

10.08

< 0.0001

Nile Red (RFU/μg)

111.0 ± 2.6

128.3 ± 15.0

122.7 ± 6.1

147.9 ± 6.1*

2.77

0.06

Cholesterol (ng/mg)

360.5 ± 20.2

340.1 ± 33.9

435.4 ± 21.9

458.4 ± 19.7*

5.02

0.011

Triglycerides (μg/mg)

11.2 ± 1.5

10.8 ± 2.0

17.1 ± 0.8*

21.0 ± 1.4**

10.3

0.0003

  1. §ALT = alanine transaminase, Nile Red, cholesterol, and tryglyceride levels were measured in liver tissue. RFU/μg = relative fluorescence units; Nile red, cholesterol and triglyceride measurements are relative to liver. Inter-group comparisons were made using ANOVA tests. For all measurements, df = 3/36. Significant differences relative to the LFD control group were demonstrated using the Dunnett's post-hoc multiple comparison test (*P < 0.05; **P < 0.01; ***P < 0.001).